119 related articles for article (PubMed ID: 16597839)
1. Agonist-induced cell surface trafficking of an intracellularly sequestered D1 dopamine receptor homo-oligomer.
Kong MM; Fan T; Varghese G; O'dowd BF; George SR
Mol Pharmacol; 2006 Jul; 70(1):78-89. PubMed ID: 16597839
[TBL] [Abstract][Full Text] [Related]
2. Activation of adenosine A1 receptor modulates dopamine D1 receptor activity in stably cotransfected human embryonic kidney 293 cells.
Cao Y; Sun WC; Jin L; Xie KQ; Zhu XZ
Eur J Pharmacol; 2006 Oct; 548(1-3):29-35. PubMed ID: 16956604
[TBL] [Abstract][Full Text] [Related]
3. Modulation of dopamine D1 receptor signaling by adenosine A1 receptors in Sf9 cells requires expression of Gi proteins.
Uustare A; Reinart R; Rinken A
Neurosci Lett; 2006 Oct; 406(3):169-73. PubMed ID: 16935419
[TBL] [Abstract][Full Text] [Related]
4. Desensitization of the dopamine D1 and D2 receptor hetero-oligomer mediated calcium signal by agonist occupancy of either receptor.
So CH; Verma V; O'Dowd BF; George SR
Mol Pharmacol; 2007 Aug; 72(2):450-62. PubMed ID: 17519357
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human D1 dopamine receptor function and gene expression in SK-N-MC neuroblastoma cells.
Sidhu A; Olde B; Humblot N; Kimura K; Gardner N
Neuroscience; 1999; 91(2):537-47. PubMed ID: 10366011
[TBL] [Abstract][Full Text] [Related]
6. Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex.
Izquierdo-Claros RM; del Boyano-Adánez M; Arilla-Ferreiro E
J Neurosci Res; 2000 Oct; 62(1):91-8. PubMed ID: 11002291
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of the human D5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities.
Cravchik A; Gejman PV
Pharmacogenetics; 1999 Apr; 9(2):199-206. PubMed ID: 10376767
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D1-D2 receptor Heteromer-mediated calcium release is desensitized by D1 receptor occupancy with or without signal activation: dual functional regulation by G protein-coupled receptor kinase 2.
Verma V; Hasbi A; O'Dowd BF; George SR
J Biol Chem; 2010 Nov; 285(45):35092-103. PubMed ID: 20807772
[TBL] [Abstract][Full Text] [Related]
9. High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype.
Tiberi M; Caron MG
J Biol Chem; 1994 Nov; 269(45):27925-31. PubMed ID: 7525564
[TBL] [Abstract][Full Text] [Related]
10. The enhancement of dopamine D1 receptor desensitization by adenosine A1 receptor activation.
Cao Y; Xie KQ; Zhu XZ
Eur J Pharmacol; 2007 May; 562(1-2):34-8. PubMed ID: 17368618
[TBL] [Abstract][Full Text] [Related]
11. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
Conroy JL; Free RB; Sibley DR
ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
[TBL] [Abstract][Full Text] [Related]
12. Differential distributions and trafficking properties of dopamine D1 and D5 receptors in nerve cells.
He Y; Yu LP; Jin GZ
Neurosci Bull; 2009 Apr; 25(2):43-53. PubMed ID: 19290022
[TBL] [Abstract][Full Text] [Related]
13. Cloning, expression, and functional analysis of human dopamine D1 receptors.
Sun WC; Jin L; Cao Y; Wang LZ; Meng F; Zhu XZ
Acta Pharmacol Sin; 2005 Jan; 26(1):27-32. PubMed ID: 15659110
[TBL] [Abstract][Full Text] [Related]
14. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
15. Receptor crosstalk protein, calcyon, regulates affinity state of dopamine D1 receptors.
Lidow MS; Roberts A; Zhang L; Koh PO; Lezcano N; Bergson C
Eur J Pharmacol; 2001 Sep; 427(3):187-93. PubMed ID: 11567648
[TBL] [Abstract][Full Text] [Related]
16. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
17. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE
J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes.
Ginés S; Hillion J; Torvinen M; Le Crom S; Casadó V; Canela EI; Rondin S; Lew JY; Watson S; Zoli M; Agnati LF; Verniera P; Lluis C; Ferré S; Fuxe K; Franco R
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8606-11. PubMed ID: 10890919
[TBL] [Abstract][Full Text] [Related]
19. Dopamine-mediated inhibition of renal Na,K-ATPase is reduced by insulin.
Banday AA; Asghar M; Hussain T; Lokhandwala MF
Hypertension; 2003 Jun; 41(6):1353-8. PubMed ID: 12707290
[TBL] [Abstract][Full Text] [Related]
20. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
